Back to Search
DANIELLE THAMM, PHARMD
PHARMD
Pharmacist
NPI: 1841701224Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature.
PMID 19330034·PLoS One·2009
3-trial
Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma.
PMID 19417014·Clin Cancer Res·2009
7-preclinical
Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers.
PMID 19422256·Langmuir·2009
8-other
Polymer-modified gadolinium metal-organic framework nanoparticles used as multifunctional nanomedicines for the targeted imaging and treatment of cancer.
PMID 19290624·Biomacromolecules·2009
7-preclinical
GS-9219--a novel acyclic nucleotide analogue with potent antineoplastic activity in dogs with spontaneous non-Hodgkin's lymphoma.
PMID 18451250·Clin Cancer Res·2008
7-preclinical
Glucose transporter 1 expression in canine osteosarcoma.
PMID 19178673·Vet Comp Oncol·2008
7-preclinical
Serum vascular endothelial growth factor concentrations and postsurgical outcome in dogs with osteosarcoma.
PMID 19178672·Vet Comp Oncol·2008
7-preclinical
Dose-escalating vinblastine for the treatment of canine mast cell tumour.
PMID 19178670·Vet Comp Oncol·2008
7-preclinical
NOD/SCID mouse model of canine T-cell lymphoma with humoral hypercalcaemia of malignancy: cytokine gene expression profiling and in vivo bioluminescent imaging.
PMID 19178662·Vet Comp Oncol·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7623 HIGHWAY 165
COLUMBIA, LA 71418 - Phone
- (318) 649-6410
Quick Facts
- NPI
- 1841701224
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile